| Original language | English |
|---|---|
| Pages (from-to) | viii266 |
| Journal | Annals of oncology : official journal of the European Society for Medical Oncology |
| Volume | 29 |
| DOIs | |
| Publication status | Published - 2018 Oct 1 |
ASJC Scopus subject areas
- Hematology
- Oncology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
TRIANgLE study (JCOG1510) : A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus. / Daiko, H.; Hara, H.; Ogawa, H.; Hori, K.; Mizusawa, J.; Ozawa, S.; Takagi, M.; Tanaka, M.; Baba, H.; Shirakawa, Y.; Tsuda, M.; Nakagawa, S.; Takeuchi, H.; Abe, T.; Ito, Y.; Kojima, T.; Kadota, T.; Fukuda, H.; Kato, K.; Kitagawa, Y.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii266.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - TRIANgLE study (JCOG1510)
T2 - A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus
AU - Daiko, H.
AU - Hara, H.
AU - Ogawa, H.
AU - Hori, K.
AU - Mizusawa, J.
AU - Ozawa, S.
AU - Takagi, M.
AU - Tanaka, M.
AU - Baba, H.
AU - Shirakawa, Y.
AU - Tsuda, M.
AU - Nakagawa, S.
AU - Takeuchi, H.
AU - Abe, T.
AU - Ito, Y.
AU - Kojima, T.
AU - Kadota, T.
AU - Fukuda, H.
AU - Kato, K.
AU - Kitagawa, Y.
PY - 2018/10/1
Y1 - 2018/10/1
UR - http://www.scopus.com/inward/record.url?scp=85081527806&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081527806&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdy282.162
DO - 10.1093/annonc/mdy282.162
M3 - Article
C2 - 32136607
VL - 29
SP - viii266
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
ER -